Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
Takahashi M, Sato T, Sagawa T, Lu Y, Sato Y, Iyama S, Yamada Y, Fukaura J, Takahashi S, Miyanishi K, Yamashita T, Sasaki K, Kogawa K, Hamada H, Kato J, Niitsu Y. Takahashi M, et al. Among authors: miyanishi k. Mol Ther. 2002 May;5(5 Pt 1):627-34. doi: 10.1006/mthe.2002.0589. Mol Ther. 2002. PMID: 11991754 Free article.
[A case of successful management of refractory ascites by transjugular intrahepatic portosystemic shunting (TIPS) in Budd-Chiari syndrome associated with alcoholic liver fibrosis].
Takahashi S, Takahashi M, Takada K, Kawano Y, Hagiwara S, Akiyama T, Sato T, Doi T, Miyanishi K, Sato Y, Kato J, Niitsu Y, Homma H, Neda H. Takahashi S, et al. Among authors: miyanishi k. Nihon Shokakibyo Gakkai Zasshi. 2002 Sep;99(9):1085-91. Nihon Shokakibyo Gakkai Zasshi. 2002. PMID: 12355897 Japanese. No abstract available.
Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
Nakajima T, Takayama T, Miyanishi K, Nobuoka A, Hayashi T, Abe T, Kato J, Sakon K, Naniwa Y, Tanabe H, Niitsu Y. Nakajima T, et al. Among authors: miyanishi k. J Pharmacol Exp Ther. 2003 Sep;306(3):861-9. doi: 10.1124/jpet.103.052696. Epub 2003 Jun 12. J Pharmacol Exp Ther. 2003. PMID: 12805482
Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1B-55K-deleted adenovirus with E1A expressed by CEA promoter.
Sagawa T, Takahashi M, Sato T, Sato Y, Lu Y, Sumiyoshi T, Yamada Y, Iyama S, Fukaura J, Sasaki K, Hamada H, Miyanishi K, Takayama T, Kato J, Niitsu Y. Sagawa T, et al. Among authors: miyanishi k. Mol Ther. 2004 Dec;10(6):1043-50. doi: 10.1016/j.ymthe.2004.08.023. Mol Ther. 2004. PMID: 15564136 Free article.
A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
Sato Y, Takayama T, Sagawa T, Okamoto T, Miyanishi K, Sato T, Araki H, Iyama S, Abe S, Murase K, Takimoto R, Nagakura H, Hareyama M, Kato J, Niitsu Y. Sato Y, et al. Among authors: miyanishi k. Cancer Chemother Pharmacol. 2006 Nov;58(5):570-6. doi: 10.1007/s00280-006-0193-x. Epub 2006 Feb 4. Cancer Chemother Pharmacol. 2006. PMID: 16463059 Clinical Trial.
277 results